◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Solar Industries India Limited (SOLARINDS) Revenue 2022–2026

Name: Solar Industries India Limited (SOLARINDS) revenue history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Solar Industries India Limited annual revenue for fiscal 2026 was ₹96.1 billion, an increase of 30.6% from ₹73.6 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

SOLARINDS Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹96.1B	₹73.6B	₹59.1B	₹67.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SOLARINDS Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹36.7B	₹30.5B	₹25.5B	₹20.8B	₹21.5B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

4612 Revenue — Nippon Paint Holdings Co., Ltd.
ASIANPAINT Revenue — Asian Paints Limited
6988 Revenue — Nitto Denko Corporation
4188 Revenue — Mitsubishi Chemical Group Corporation
PIDILITIND Revenue — Pidilite Industries Limited
4183 Revenue — Mitsui Chemicals, Inc.

More SOLARINDS metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All SOLARINDS financial statements → Interactive SOLARINDS charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.